Lamivudine-based two-drug regimens with dolutegravir or protease inhibitor: Virological suppression in spite of previous therapy failure or renal dysfunction

CONCLUSIONS: The 2DR is feasible, with robust suppression rates, even when 3TC resistance or renal dysfunction is present, and close monitoring of these cases may guarantee long-term suppression.PMID:36809850 | DOI:10.1016/j.bjid.2023.102757

Source: Braz J Infect Dis - February 22, 2023 Category: Infectious Diseases Authors: Elaine Monteiro Matsuda Ivana Barros Campos Isabela Penteriche de Oliveira Daniela Rodrigues Colpas Giselle Ibete Silva L ópez-Lopes Victor Oliveira Chiavegato Lu ís Fernando de Macedo Brígido Source Type: research